Pattern recognition of neurotransmitters using multimode sensing

Journal of Neuroscience Methods

Volumn 229, Issue , 2014, Pages 1-7

  Stefan van Staden, Raluca Ioana ^a,b   Moldoveanu, Iuliana ^a,b   van Staden, Jacobus Frederick ^a  

^a Institute of Biology Bucharest   (Romania)

^b UNIVERSITY POLITEHNICA OF BUCHAREST   (Romania)

Author keywords

Diamond paste, Multimode sensing; Neurotransmitters, Pattern recognition

Indexed keywords

5,10,15,20 TETRAPHENYL 21H,23H PORPHYRINE; ADRENALIN; DIAMOND; DOPAMINE; ELECTROLYTE; HEMIN; NEUROTRANSMITTER; NORADRENALIN; PHOSPHATE BUFFERED SALINE; PORPHYRIN DERIVATIVE; POTASSIUM CHLORIDE; PROTOPORPHYRIN; UNCLASSIFIED DRUG; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS;

ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CONTROLLED STUDY; CYCLIC POTENTIOMETRY; DIFFERENTIAL PULSE VOLTAMMETRY; HUMAN; LIMIT OF QUANTITATION; MULTIMODE MICROSENSOR; MULTIMODE SENSING; NEUROLOGICAL AND SENSORIAL PROCEDURES; NEUROLOGICAL DIAGNOSTIC DEVICE; PATTERN RECOGNITION; PH; PRIORITY JOURNAL; URINALYSIS; URINE LEVEL; WORK ENVIRONMENT; ATOMIC FORCE MICROSCOPY; AUTOMATED PATTERN RECOGNITION; BLOOD ANALYSIS; CHEMISTRY; DEVICES; GENETIC PROCEDURES; PROCEDURES; SENSITIVITY AND SPECIFICITY; STATISTICS; URINE;

BIOSENSING TECHNIQUES; BLOOD CHEMICAL ANALYSIS; DIAMOND; DOPAMINE; EPINEPHRINE; MICROCHEMISTRY; MICROSCOPY, ATOMIC FORCE; NEUROTRANSMITTER AGENTS; NOREPINEPHRINE; PATTERN RECOGNITION, AUTOMATED; SENSITIVITY AND SPECIFICITY; STOCHASTIC PROCESSES; URINE;

EID: 84903317166     PISSN: 01650270     EISSN: 1872678X     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2014.03.008     Document Type: Article

References (37)

1. Abdulrahman L.K., Al-Abachi A.M., Al-Qaissy M.H. Flow injection-spectrophotometeric determination of some catecholamine drugs in pharmaceutical preparations via oxidative coupling reaction with p-toluidine and sodium periodate. Anal Chim Acta 2005, 538:331-335.
2. Bailard N.S., Ortiz J., Flores R.A. Additives to local anesthetics for peripheral nerve blocks: evidence, limitations, and recommendations. Am J Health Syst Pharm 2014, 71:373-385.
3. Cotella E.M., Lascano I.M., Levin G.M. Amitriptyline treatment under chronic stress conditions: effect on circulating catecholamines and anxiety in early maternally separated rats. Int J Neurosci 2009, 119:664-680.
4. Damier P., Hirsch E.C., Agid Y., Graybiel A.M. The substantianigra of the human brain II patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain 1999, 122:1437-1448.
5. El-Kommos M.E., Mohamed F.A., Khedr A.S. Spectrophotometric determination of epinephrine and norepinephrine with sodium periodate. Talanta 1990, 37:625-627.
6. Flaa A., Eide I.K., Kjeldsen S.E., Rostrup M. Sympathoadrenal stress reactivity is a predictor of future blood pressure: an 18-year follow-up study. Hypertension 2008, 52:336-341.
7. Fotopoulou M.A., Ioannou P.C. Post-column terbium complexation and sensitized fluorescence detection for the determination of norepinephrine, epinephrine and dopamine using high-performance liquid chromatography. Anal Chim Acta 2002, 462:179-185.
8. Garcia J.C., Blanco L., McPherson M., Leiva A., Macias R. High-performance liquid chromatographic determination of norepinephrine, epinephrine and dopamine in human foetal adrenal gland. J Chromatogr B 1994, 656:77-80.
9. Gluck M.R., Santana L.A., Granson H., Yahr M.D. Novel dopamine releasing response of an anti-convulsant agent with possible anti-Parkinson's activity. J Neural Transm 2004, 111:713-724.
10. Goyal R.N., Bishnoi S. Simultaneous determination of epinephrine and norepinephrine in human blood plasma and urine samples using nanotubes modified edge plane pyrolytic graphite electrode. Talanta 2011, 84:78-83.
11. Grossman M., Glosser G., Kalmanson J., Morris J., Stern M.B., Hurtig H.I. Dopamine supports sentence comprehension in Parkinson's disease. J Neurol Sci 2001, 184:123-130.
12. Imai K., Higashidate S., Prados P., Santa T., Adachi-Akahane S., Nagao T. Relation between blood pressure and plasma catecholamine concentration after administration of calcium antagonists to rats. Biol Pharm Bull 1994, 17:907-914.
13. Kissinger P.T., Bruntlett C.S., Shoup R.E. Neurochemical applications of liquid chromatography with electrochemical detection. Life Sci 1981, 28:455-465.
14. Li Y., Umasankar Y., Chen S.M. Multiwalled carbon nanotubes with poly(NDGAChi) biocomposite film for the electrocatalysis of epinephrine and norepinephrine. Anal Biochem 2009, 388:288-295.
15. Malem F., Mandler D. Self-assembled monolayers in electroanalytical chemistry: application of omega-mercaptocarboxylic acid monolayers for the electrochemical detection of dopamine in the presence of a high concentration of ascorbic acid. Anal Chem 1993, 65:37-41.
16. Mazloum-Ardakani M., Beitollahi H., Ganjipour B., Naeimi H. Novel carbon nanotube paste electrode for simultaneous determination of norepinephrine, uric acid and d-penicillamine. Int J Electrochem Sci 2010, 5:531-546.
17. Michael D.J., Wightman R.M. Electrochemical monitoring of biogenic amine neurotransmission in real time. J Pharm Biomed Anal 1999, 19:33-46.
18. Mravec B., Tillinger A., Bodnar I., Nagy G.M., Palkovits M., Kvetňanský R. The response of plasma catecholamines in rats simultaneously exposed to immobilization and painful stimuli. Ann N Y Acad Sci 2008, 1148:196-200.
19. O'Neill R.D. Microvoltammetric techniques and sensors for monitoring neurochemical dynamics in vivo. Analyst 1994, 119:767-779.
20. Phillips P.E.M., Stuber G.D., Heien M.L.A.V., Mark R. Subsecond dopamine release promotes cocaine seeking. Nature 2003, 422:614-618.
21. Ren W., Luo H.Q., Bing N.L. Simultaneous voltammetric measurement of ascorbic acid, epinephrine and uric acid at a glassy carbon electrode modified with caffeic acid. Biosens Bioelectron 2006, 21:1086-1092.
22. Sanghavi B.J., Mobin S.M., Mathur P., Lahiri G.K., Srivastava A.K. Biomimetic sensor for certain catecholamines employing copper(II) complex and silver nanoparticle modified glassy carbon paste electrode. Biosens Bioelectron 2013, 39:124-132.
23. Seol H., Jeong H., Jeon S. A selective determination of norepinephrine on the glassy carbon electrode modified with poly(ethylenedioxypyrroledicarboxylic acid) nanofibers. J Solid State Electrochem 2009, 13:1881-1887.
24. Slavikova J., Kuncova J., Topolcan O. Plasma catecholamines and ischemic heart disease. Clin Cardiol 2007, 30:326-330.
25. Smith T.E., Devlin T.M. Textbook of Biochemistry with Clinical Correlations 1992, Wiley-Liss, New York. 4th ed.
26. Sorouraddin M.H., Manzoori J.L., Kargarzadeh E., Haji Shabani A.M. Spectrophotometric determination of some catecholamine drugs using sodium bismuthate. J Pharm Biomed Anal 1998, 18:877-881.
27. Stefan-van Staden R.I., Moldoveanu I. Stochastic sensors based on nanostructured materials used in the screening of whole blood for hepatitis B. J Electrochem Soc 2014, 161:B3001-B3005.
28. Stefan-van Staden R.I., Nejem R.M., van Staden J.F., Aboul-Enein H.Y. Determination of l- and d-fucose using amperometric electrodes based on diamond paste. Analyst 2012, 137:903-909.
29. Thiagarajan S., Yang R.F., Chen S.M. Palladium nanoparticles modified electrode for the selective detection of catecholamine neurotransmitters in presence of ascorbic acid. Bioelectrochemistry 2009, 75:163-169.
30. Wang J. Selectivity coefficients for amperometric sensors. Talanta 1994, 41:857-863.
31. Wang Y., Chen Z.Z. A novel poly(taurine) modified glassy carbon electrode for the simultaneous determination of epinephrine and dopamine. Coll Surf B Biointerfaces 2009, 74:322-327.
32. Wang Y., Fice D.S., Yeung P.K.F. A simple high-performance liquid chromatography assay for simultaneous determination of plasma norepinephrine, epinephrine, dopamine and 3,4-dihydroxyphenyl acetic acid. J Pharm Biomed Anal 1999, 21:519-525.
33. Wei M., Li M., Li N., Gua Z., Duanb X. Electrocatalytic oxidation of norepinephrine at a reduced C60-[dimethyl-(β-cyclodextrin)]2 and nafion chemically modified electrode. Electrochim Acta 2002, 47:2673-2678.
34. Wightman R.M., Amatore C., Engstrom R.C., Hale P.D. Real-time characterization of dopamine overflow and uptake in the rat striatum. Neuroscience 1988, 25:13-23.
35. Wong D.L. Epinephrine biosynthesis: hormonal and neural control during stress. Cell Mol Neurobiol 2006, 26:891-900.
36. Yu N., Tucker K.R., Levitan E.S., Shepard P.D., Canavier C.C. Implications of cellular models of dopamine neurons for schizophrenia. Prog Mol Biol Transl Sci 2014, 123:53-82.
37. Yufu K., Okada N., Ebata Y., Murozono Y., Shinohara T., Nakagawa M., et al. Plasma norepinephrine is an independent predictor of adverse cerebral and cardiovascular events in type 2 diabetic patients without structural heart disease. J Cardiol 2014, pii:S0914-5087:00012-4. 10.1016/j.jjcc.2013.12.009.